Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and AustraliaAdriano Lazzarin, Miklos Salgo, Jacques Reynes et al.|New England Journal of Medicine|2003Cited by 653
The spread, treatment, and prevention of HIV-1: evolution of a global pandemicMyron S. Cohen, Joep M. A. Lange, Nick Hellmann et al.|Journal of Clinical Investigation|2008Cited by 308
Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical TrialsMark Nelson, Miklos Salgo, Keikawus Arastéh et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2005Cited by 151